70 results match your criteria: "hospital Paul Brousse[Affiliation]"
Hepatology
July 2024
Department of Gastroenterology and Hepatology, Erasmus MC Transplant Institute, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
Background And Aims: Management of Budd-Chiari syndrome (BCS) has improved over the last decades. The main aim was to evaluate the contemporary post-liver transplant (post-LT) outcomes in Europe.
Approach And Results: Data from all patients who underwent transplantation from 1976 to 2020 was obtained from the European Liver Transplant Registry (ELTR).
Transplantation
October 2023
Department of Surgery, Centennial Hall Kyushu University School of Medicine, Kyushu, Japan.
Front Psychiatry
July 2023
Connecticut Mental Health Center, New Haven, CT, United States.
Am J Obstet Gynecol
February 2024
Department of Obstetrics, Fetal-Medicine, and Surgery, Necker-Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris, University of Paris, Paris, France. Electronic address:
Objective: Recent studies have shown that a dosage of 8 g/d of oral valacyclovir reduces substantially the vertical transmission rate of cytomegalovirus in women with primary cytomegalovirus infection acquired periconceptionally or during the first trimester of pregnancy. This individual patient data meta-analysis aimed to assess the effectiveness and safety of valacyclovir treatment in the secondary prevention of congenital cytomegalovirus infection.
Data Sources: MEDLINE, Scopus, Cochrane Central Register of Controlled Trials, the US registry of clinical trials (www.
JHEP Rep
February 2023
Department of Hepatology, Medical Liver Transplant Unit, Hospital Henri Mondor AP-HP, University of Paris-Est Créteil (UPEC), France.
Background & Aims: Two recently developed composite models, the alpha-fetoprotein (AFP) score and Metroticket 2.0, could be used to select patients with hepatocellular carcinoma (HCC) who are candidates for liver transplantation (LT). The aim of this study was to compare the predictive performance of both models and to evaluate the net risk reclassification of post-LT recurrence between them using each model's original thresholds.
View Article and Find Full Text PDFTher Adv Med Oncol
September 2022
Department of Digestive and Medical Oncology, Hôpital Paul Brousse (AP-HP), 12 Avenue Paul Vaillant-Couturier, Villejuif 94800, University of Paris Saclay, France.
Mortality from pancreatic ductal adenocarcinoma (PDAC) is increasing worldwide and effective new treatments are urgently needed. The current treatment of metastatic PDAC in fit patients is based on two chemotherapy combinations (FOLFIRINOX and gemcitabine plus nab-paclitaxel) which were validated more than 8 years ago. Although almost all treatments targeting specific molecular alterations have failed so far when administered to unselected patients, encouraging results were observed in the small subpopulations of patients with germline mutations, and somatic gene fusions ( 1, which are enriched in KRAS wild-type PDAC), G12C mutations, or microsatellite instability.
View Article and Find Full Text PDFBr J Surg
February 2023
Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
Int J Cancer
December 2022
Gastrointestinal Oncology Department, Hôpital Européen Georges Pompidou, AP-HP, Université de Paris, Paris, France.
After failure of first line FOLFOX-bevacizumab for metastatic colorectal cancer (mCRC), adding either bevacizumab or aflibercept to second-line FOLFIRI increases survival compared to FOLFIRI alone. In this French retrospective multicentre cohort, we included patients with a mCRC treated with either FOLFIRI-aflibercept or FOLFIRI-bevacizumab. The primary endpoint was overall survival (OS), and secondary endpoints were progression-free survival (PFS), disease control rate (DCR: CR + PR + SD) and safety.
View Article and Find Full Text PDFGastro Hep Adv
May 2022
INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique, Sorbonne Université, Paris, France.
Background And Aims: The liver cancer risk test (LCR1-LCR2) is a multianalyte blood test combining proteins involved in liver cell repair (apolipoprotein A1, haptoglobin), hepatocellular carcinoma (HCC) risk factors (gender, age, gamma glutamyl transpeptidase), a marker of fibrosis (alpha2-macroglobulin), and alpha-fetoprotein, a specific marker of HCC. The aim was to externally validate LCR1-LCR2 in hepatitis B.
Methods: Preincluded patients were from the Hepather cohort, a multicenter, multiethnic prospective study in 6071 patients.
JHEP Rep
May 2022
Hospital Henri Mondor, University of Paris-Est, Creteil, France.
Background & Aims: Patients with hepatocellular carcinoma (HCC) are selected for liver transplantation (LT) based on pre-LT imaging ± alpha-foetoprotein (AFP) level, but discrepancies between pre-LT tumour assessment and explant are frequent. Our aim was to design an explant-based recurrence risk reassessment score to refine prediction of recurrence after LT and provide a framework to guide post-LT management.
Methods: Adult patients who underwent transplantation between 2000 and 2018 for HCC in 47 centres were included.
Elife
February 2022
Department of Experimental Psychology, University of Oxford, Oxford, United Kingdom.
Growing evidence shows that sex differences impact many facets of human biology. Here we review and discuss the impact of sex on human circadian and sleep physiology, and we uncover a data gap in the field investigating the non-visual effects of light in humans. A virtual workshop on the biomedical implications of sex differences in sleep and circadian physiology led to the following imperatives for future research: i) design research to be inclusive and accessible; ii) implement recruitment strategies that lead to a sex-balanced sample; iii) use data visualization to grasp the effect of sex; iv) implement statistical analyses that include sex as a factor and/or perform group analyses by sex, where possible; v) make participant-level data open and available to facilitate future meta-analytic efforts.
View Article and Find Full Text PDFTher Adv Med Oncol
November 2021
Department of Biostatistics, University of Washington, Seattle, WA, USA.
The treatment paradigm for locally advanced pancreatic cancer (LAPC) is evolving rapidly. The development of neoadjuvant therapies composed of combination therapies and the evaluation of their impact on conversion to borderline resectable (BR) status, resection, and ultimately overall survival (OS) are presently being pursued. These efforts justify re-visiting study endpoints in order to better predict therapeutic effects on OS, by capturing not only the achievement of R0 resection at the end of induction therapy but also the long-term reductions in the rate of local and distal recurrence.
View Article and Find Full Text PDFLiver Int
February 2022
Centre Hepatobiliaire, University Hospital Paul Brousse, University Paris-Saclay and Inserm-Paris Saclay Research Unit 1193, Villejuif, France.
Chronic hepatitis B virus (HBV) infection is the major aetiology of hepatocellular carcinoma (HCC). The optimal goal of therapy, hepatitis B surface antigen (HBsAg) loss and anti-HBs production, is achieved rarely and HBsAg-associated HCC risk is well recognized. Here we review the role of HBsAg in HCC, the link between HBsAg and HCC recurrence post-liver transplantation or resection, and the implications for therapy.
View Article and Find Full Text PDFEncephale
October 2022
UFR des Sciences de la Santé Simone Veil (UVSQ), Praticienne Hospitalière, Fondation Santé des Étudiants de France, Clinique E Rist, 8, rue E. Deutsch-de-la-Meurthe, 75014 Paris, France. Electronic address:
Background: Hospitalization is rare in anorexia nervosa (AN) and local application of indications is heterogeneous. However, no study has evaluated the effect of these different treatment modalities on the mean length of stay. Our objective was to describe the context and modalities of a wide range of hospital care programs offered to patients with anorexia nervosa in eleven specialized French psychiatric centers for patients from childhood to adulthood.
View Article and Find Full Text PDFGut
October 2021
Department of Surgery, Erasmus Medical Center, Rotterdam, The Netherlands.
Objective: Explore the impact of COVID-19 on patients on the waiting list for liver transplantation (LT) and on their post-LT course.
Design: Data from consecutive adult LT candidates with COVID-19 were collected across Europe in a dedicated registry and were analysed.
Results: From 21 February to 20 November 2020, 136 adult cases with laboratory-confirmed SARS-CoV-2 infection from 33 centres in 11 European countries were collected, with 113 having COVID-19.
JHEP Rep
August 2021
Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique, Paris, France.
Background & Aims: The Liver Cancer Risk test algorithm (LCR1-LCR2) is a multianalyte blood test combining proteins involved in liver cell repair (apolipoprotein-A1 and haptoglobin), known hepatocellular carcinoma (HCC) risk factors (sex, age, and gamma-glutamyl transferase), a marker of fibrosis (alpha2-macroglobulin) and alpha-fetoprotein (AFP), a specific marker of HCC. The aim was to externally validate the LCR1-LCR2 in patients with chronic HCV (CHC) treated or not with antivirals.
Methods: Pre-included patients were from the Hepather cohort, a multicentre prospective study in adult patients with CHC in France.
Sci Rep
June 2021
Department of Medical Oncology, Hospital Paul-Brousse, University Paris-Saclay, Assistance Publique-Hôpitaux de Paris (APHP), 94800, Villejuif, France.
Supplementation of cancer cells exposed to 5-fluorouracil (FUra) and folinic acid (FA) with high concentration pyridoxal 5'-phosphate, the cofactor of vitamin B6, potentiates the cytotoxicity of FUra in a synergistic interaction mode. We report a pilot study in 13 patients with previously untreated advanced carcinoma of the digestive tract to assess the impact of high-dose pyridoxine (PN) on the antitumor activity of regimens comprising FUra and FA. Five patients had colorectal adenocarcinoma (CRC); 5 had pancreas adenocarcinoma (PC); and 3 had squamous cell carcinoma of the esophagus (EC).
View Article and Find Full Text PDFFront Oncol
December 2019
Department of Pediatric Hematology and Immunology, University Hospital Robert Debré, Assistance Publique des Hôpitaux de Paris (APHP), Paris, France.
B-cell acute lymphoblastic leukemia associated with t(5;14)(q31;q32); is an exceptional cause of eosinophilia. The enhancer on 14q32 is juxtaposed to the gene on 5q31, leading to interleukin-3 overproduction and release of mature eosinophils in the blood. Clinical, biological and outcome data are extremely scarce in the literature.
View Article and Find Full Text PDFTransplant Proc
December 2019
Department of Abdominal Transplant Surgery, University Hospitals Leuven, KU Leuven, Leuven, Belgium. Electronic address:
Background: Surgical factors and direct cytotoxicity of bile salts on cholangiocytes may play a role in the development of ischemic cholangiopathy (IC) after liver transplantation (LTx). There is no validated consensus on how to protect the bile ducts during procurement, static preservation, and LTx. Meanwhile, IC remains the most troublesome complication after LTx.
View Article and Find Full Text PDFJ Pharmacol Exp Ther
June 2019
Assistance Publique-Hôpitaux de Paris, Hospital Paul-Brousse, Villejuif, France (D.M., J.H., E.G., R.S.,); INSERM U935, Villejuif, France (D.M., C.D., F.H.-R., C.B.); University Paris-Sud, Villejuif, France (D.M., J.H., C.D., R.M., F.H.-R., C.B., R.S.); University Paris-Saclay, Paris, France (D.M., J.H., C.D., R.M., F.H.-R., C.B., R.S.); University of Urbino Carlo Bo, Urbino, Italy (L.R., F.P., M.M.); INSERM U1193, Villejuif, France (J.H., R.S.); INSERM U1197, Villejuif, France (R.M.); INRA-AgroParisTech, UMR 782 GMPA, Thiverval-Grignon, France (P.Bo.); Institut Jean-Pierre Bourgin, INRA-AgroParisTech, University Paris-Saclay, Versailles, France (P.Br.); CRH-Department of Protein Biochemistry and Proteomics, Palacký University, Olomouc, Czech Republic (D.K.); YGM Consult SAS, Paris, France (Y.G.-M.); CNRS UMR 8601, Paris, France (J.D.); Assistance Publique-Hôpitaux de Paris, Hospital Necker-Enfants Malades, Paris. France (B.C.-V.); and University Paris-Descartes, Paris, France (B.C.-V., J.D.).
Methionine deprivation induces growth arrest and death of cancer cells. To eliminate l-methionine we produced, purified, and characterized the recombinant pyridoxal 5'-phosphate (PLP)-dependent l-methionine -lyase (MGL)- BL929 from the cheese-ripening Transformation of an strain with the gene from optimized for expression led to production of the MGL-BL929. Elimination of l-methionine and cytotoxicity in vitro were assessed, and methylation-sensitive epigenetics was explored for changes resulting from exposure of cancer cells to the enzyme.
View Article and Find Full Text PDFCurr Neuropharmacol
September 2019
Geneva University Hospitals, Geneva, Switzerland.
Background: The concept of food addiction attracts much interest in the scientific community. Research is mainly based on the Yale Food Addiction Scale (YFAS), a tool developed to assess food addiction. Substance use disorder criteria have been used to develop this scale.
View Article and Find Full Text PDFCrit Care Med
November 2018
European Foundation for the study of Chronic Liver Failure, Barcelona, Spain.
Objectives: To evaluate the Chronic Liver Failure-Consortium Acute on Chronic Liver Failure score in acute on chronic liver failure patients admitted to ICUs from different global regions and compare discrimination ability with previously published scores.
Design: Retrospective pooled analysis.
Setting: Academic ICUs in Canada (Edmonton, Vancouver) and Europe (Paris, Barcelona, Chronic liver failure/Acute-on-Chronic Liver Failure in Cirrhosis [CANONIC] study).
Placenta
May 2018
University Paris Saclay Saint-Aubin, France; INSERM U1197 Stem Cell-Niches Interactions: Physiology, Tumors and Tissular Repair, Hospital Paul Brousse, Bâtiment Lavoisier, Villejuif, France. Electronic address:
Introduction: Hydatidiform mole (HM) is an aberrant human pregnancy with abnormal trophoblastic development, migration/invasion of the extravillous trophoblast in the decidua. These abnormalities are established in a hypoxic environment during the first trimester of gestation.
Methods: Using text mining, we identified 72 unique genes that are linked to HM (HM-linked genes) that we studied by bioinformatic analysis in publicly available transcriptomes of primary chorionic villous cells (cytotrophoblast, syncytiotrophoblast, extravillous trophoblast, and arterial and venous endothelial) isolated from normal placentas or established trophoblastic cell lines cultured under different oxygen concentrations.
J Pharmacol Exp Ther
August 2018
Assistance Publique-Hôpitaux de Paris, Hospital Paul-Brousse, Villejuif, France (D.M., E.G., R.S.); INSERM U935, Villejuif, France (D.M., F.H.-R., C.D., C.B.); University Paris-Sud, Villejuif, France (D.M., R.M., F.H.-R., C.D., R.S., C.B.); University Paris-Saclay, Paris, France (D.M., R.M., F.H.-R., C.D., R.S., C.B.); INSERM U1193, Villejuif, France (R.S.); INSERM U1197, Villejuif, France (R.M.); YGM Consult SAS, Paris, France (Y.G.-M.); CNRS UMR 8601, Paris, France (J.D.); and University Paris-Descartes, Paris, France (J.D.).
The current study originates from the assumption that, in tumors, levels of naturally occurring pyridoxal 5'-phosphate (PLP) are too small to allow conversion of tetra hydro pteroylglutamate (HPteGlu) into methylene tetra hydro pteroylglutamate (CH-HPteGlu) in amounts required to improve inhibition of thymidylate synthase by 5-fluorouracil (FUra) through ternary complex stabilization. The hypothesis relates to the low affinity for cofactor of the PLP-dependent serine hydroxymethyl transferase (SHMT), the enzyme that catalyzes formation of CH-HPteGlu by transfer of the C of serine to HPteGlu. Intracellular concentrations of PLP are smaller than the dissociation constant of SHMT for cofactor, which suggests that enzyme activity should be sensitive to PLP level changes.
View Article and Find Full Text PDFMicrobes Infect
April 2019
Laboratory Animal Center of the Academy of Military Medical Science, Beijing, 100071, China. Electronic address: